fda approves semaglutide First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity FDA Approves Semaglutide to Reduce
Description
While semaglutide mimics hormones that regulate hunger and satiety, Topamax influences the nervous system, resulting in a more indirect effect on cravings and appetite. Note: Please do not stop taking Topamax without consulting your doctor and under medical supervision

A diet rich in fiber, lean proteins, and whole grains is recommended to help minimize side effects while supporting overall health and digestion

When you stop taking semaglutide, the appetite suppression fades within a few weeks, and most people regain a significant portion of their lost weight over the following six to twelve months

It is important to distinguish between direct causation and indirect effects that may occur as a consequence of the medication's primary actions, particularly its effect on weight loss
